Skip to content
Breaking News Desk Editorial

Supreme Court Criticizes Government Over Medical Treatment Price Discrepancies: Healthcare Stocks React with Declines

Supreme Court Criticizes Government Over Medical Treatment Price Discrepancies: Healthcare Stocks React with Declines
Abhishek Sharma
Founder & Editor-in-Chief
Published: Updated: 2 min read
AdvertisementAdvertisement

Hospital stocks are in the spotlight with all experiencing declines ranging from 3% to 9%. Companies such as Max Healthcare, Fortis Healthcare, Apollo Hospital, Medanta,, and Jupiter Life Line Hospitals are among those affected.

The Supreme Court of India has taken a stern stance on the considerable price variations in medical treatments between government and private healthcare establishments. In a recent hearing of a public interest litigation (PIL) brought forth by the Veterans Forum for Transparency in Public Life, the court criticized the central government for its failure to enforce the Clinical Establishment (Central Government) Rules, which were instituted 14 years ago. These rules were designed to establish a standardized fee structure for various medical procedures, with rates reflecting regional living standards.

The PIL urged the government, particularly under Rule 9 of the Clinical Establishment Rules, 2012, to set up a regulated fee system for patients. This rule mandates healthcare facilities to transparently display service charges in local languages and English, ensuring that the prices fall within the range specified by the central government in consultation with state governments.

Despite the central government’s claims of reaching out to state governments for cooperation, the Supreme Court firmly asserted that providing affordable healthcare is a fundamental right that cannot be ignored. Consequently, the court directed the Union health secretary to promptly convene a meeting with health secretaries from all states within a month. The objective is to ensure the expeditious notification of standardized rates. The court issued a warning that if the central government fails to find a resolution, they would consider the petitioner’s plea to implement standardized rates prescribed by the Central Government Health Scheme (CGHS).

This development underscores the judiciary’s commitment to addressing issues of healthcare affordability in India. The directive to convene a meeting reflects the court’s proactive approach in holding the government accountable for enforcing regulations that would lead to consistent and reasonable pricing across medical facilities, ultimately ensuring accessible healthcare for all citizens.

🚀
⚡ Prime
Enjoy an Ad-Free Reading Experience
Plus 100+ screener conditions, historical signal analysis, DIY stock screening, FII/DII data & more.
Join Prime →
Abhishek Sharma
Founder & Editor-in-Chief

Abhishek Sharma

I’m Abhishek Sharma, an Advocate based in Delhi, entrepreneur, investor, and founder of BigBreakingWire. I am an enrolled Advocate with a strong interest in entrepreneurship, media, and technology. I founded BigBreakingWire, a digital news platform covering breaking news, business, financial markets, companies, and important developments in India and around the world. I also have a software company and take an active interest in technology, software, AI, digital products, and new business ideas. As an investor, I’m interested in discovering and investing in promising businesses and startups. I look for good ideas, strong founders, practical business models, and opportunities with long-term potential. I enjoy building businesses, learning about new industries, and connecting with people who are working on interesting ideas and opportunities. Advocate | Entrepreneur | Investor | Founder & Editor-in-Chief, BigBreakingWire

Last reviewed by Abhishek Sharma on August 31, 2026

Disclaimer: BigBreakingWire provides news and informational content for general educational purposes only. The information presented on this website does not constitute financial, investment, tax, or legal advice. Readers should consult qualified professionals before making any financial decisions. BigBreakingWire, its authors, and editors are not responsible for any financial losses or damages arising from the use of information on this site.

Discussion

Share your take — react and comment in seconds, no login needed.

0 comments

Loading discussion…

Be civil — abusive or promotional comments get removed. No login required.

Also in

⚡ Upgrade to Prime
The Market Terminal for Serious Investors
🚫 Ad-Free Experience📊 100+ Screener Conditions🔬 Historical Signals📈 DIY Stock Screening🏦 FII/DII Data
Join BigBreakingWire Prime →